Activist Investor Galloway Capital Takes 8.42% Stake in WW International
WW International rose after Galloway Capital built 8.42% stake, saying company is undervalued despite debt issues.
/ 1656 items
#XY↓
UBS Turns Bullish on CORT: Lifyorli Expected to Beat Expectations
UBS upgraded CORT to Buy, raised target to $72 on strong Lifyorli cancer drug outlook and steady Korlym sales. Upside ~60–70%.
Zydus Beats Garda with $166 Million All-Cash Takeover of Assertio
Zydus will buy Assertio for $166.4M, paying $23.50/share, giving shareholders more value and taking the company private.
Insider Buying Sends Pulse Biosciences Stock Higher
Pulse Biosciences stock jumped after top executives bought $13M in shares, signaling strong confidence in future growth.
MacroGenics Sells GMP Manufacturing Operations to Bora Pharmaceuticals for $122.5 Million
MacroGenics sells manufacturing site to Bora for $122.5M, keeps access, gains cash, and focuses on cancer drug development.
Rigel Pharmaceuticals Lands Exclusive Global Deal for Breakthrough Breast Cancer Drug Veppanu
Arvinas & Pfizer partner with Rigel to launch Veppanu, a new oral breast cancer drug showing strong results and better survival.